Product: Accumulus Platform

Company: Accumulus Technologies

About the Product:

The Accumulus Platform transforms regulatory review from isolated national activities into a connected global regulatory ecosystem. Purpose-built for regulatory collaboration, the cloud-based Platform enables life sciences companies and regulatory authorities to securely share, review, and discuss evidence as it evolves. Rather than relying on episodic, sequential submissions, Accumulus enables continuous engagement and real-time collaboration across the regulatory lifecycle. With more than 75 regulatory authorities connected worldwide, the Platform establishes the foundation for a more efficient, data-driven model of healthcare innovation—reducing fragmentation, accelerating regulatory review, and ultimately supporting faster access to life-changing medicines for patients around the world.

Product: AEYE-DS (AEYE Diagnostic Screening)

Company: AEYE Health

About the Product:

AEYE-DS is the first fully autonomous, portable AI diagnostic solution approved by the FDA. Requiring no physician interpretation, one image per eye, and no dilation, AEYE-DS delivers an immediate diabetic retinopathy diagnosis. Diabetic retinopathy is the leading cause of blindness among working-age adults, yet early detection can prevent vision loss. By bringing sight-saving eye exams directly into primary care, endocrinology, and other points of care, AEYE-DS removes major barriers preventing hundreds of millions of people with diabetes from receiving recommended annual screening. Today, AEYE-DS is the fastest-growing U.S. diabetic eye exam solution, preventing blindness for many patients every day.

Product: AI-Enabled Virtual Specialty GI Clinic

Company: Ayble Health

About the Product:

Ayble Health is the world’s first AI-enhanced, full-spectrum virtual clinic for digestive health, democratizing access to the multidisciplinary care model of premier academic medical centers. Backed by 16 peer-reviewed publications, Ayble holds the Peterson Health Technology Institute’s highest evidence quality rating. The platform combines clinical, dietary, behavioral, and pharmaceutical interventions for each patient, using two billion data points to precisely match each patient to the care plan that works best for them. Ayble improves outcomes for 94% of patients, typically within 4 weeks, and lowers annual care costs by $2,900-6,000+ per patient, setting a new benchmark for chronic care.

Product: The TeleDentists® Virtual Dental Care Platform

Company: Cleerly

About the Product:

Cleerly LABS is an FDA-cleared, AI-powered tool that analyzes CCTA images to detect and characterize coronary artery plaque, providing physicians with comprehensive insights for cardiovascular disease evaluation and management. The machine-learning AI generates a 3D model of the patient's coronary arteries, identifies lumen and vessel walls, locates and measures stenoses, and quantifies and categorizes plaque composition and burden. Cleerly LABS addresses clinical needs across diverse cardiovascular patient populations, providing noninvasive, individualized coronary artery disease evaluation and supports clinical decision-making from emergency settings to preventive care.

Product: Felix NeuroAI Wristband

Company: Fasikl

About the Product:

Felix NeuroAI™ Wristband is an FDA-cleared, noninvasive AI therapeutic for essential tremor. Unlike conventional AI used for diagnosis or decision support, Felix uses AI as an active therapeutic modality, creating a continuously adaptive interaction between artificial intelligence and the human nervous system. Through personalized neuromodulation, AI and the brain learn and adapt together to improve motor control. A single wrist-worn device can treat tremor in both upper limbs, provide sustained all-day benefit, and demonstrate progressive improvement over time. Felix establishes a new class of AI therapeutics that harnesses the nervous system’s intrinsic capacity for learning and adaptation to restore function.

Product: MedGPT-AI Digital Twin of Doctors

Company: Future Doctor Inc

About the Product:

MedGPT, developed by Future Doctor Limited., is the world’s first large-scale deployed AI digital twin of physicians, designed to replicate the cognitive processes and workflows of top-tier doctors. Covering the full continuum of care—prevention, diagnosis, treatment, and rehabilitation—MedGPT addresses over 95% of common clinical encounters, reduces treatment costs by up to 86%, and achieves 96% diagnostic concordance with leading physicians from top Chinese hospitals. By enabling a tenfold increase in physician productivity, MedGPT redefines care delivery, improves equity of access, and helps overcome the “impossible triangle” of quality, cost, and efficiency in healthcare.

Product: Gheorg, Mental Health App
Democratizing Therapy Support for Children

Company: Gheorg

About the Product:

Gheorg is a mental health app democratizing therapy support for children offering intervention, prevention, and equitable care 365/24/7.  Gheorg is a human-in-the-loop, telehealth app that improves emotional intelligence and mental well-being for kids aged 5-12 with the five top mental health issues.  Gheorg offers AI, real practical field intelligence and evidence-based psychologies through friendly characters that engage children in independent, interactive activities.  A parent portal and/or clinician dashboard provides real-time monitoring and allows for other input.  Children learn to identify, articulate, and cope with triggers.  Gheorg also provides substantial cost savings, engagement, and service enhancements for providers. Gheorg.

Product: Helfie

Company: Helfie

About the Product:

Helfie is building the world's first Human Health Network by pairing everyone with their own personal Health Intelligence (HI). With 30+ health checks accessible via smartphone, the Health Intelligence monitors the user's health, providing deep insights and personalised advice. This transforms healthcare from reactive treatment to a system built around early detection and proactive prevention to extend life and improve wellbeing. At population scale, this intelligence helps Governments reach more people while reducing healthcare costs, building the foundation for a health economy optimised for the individual, no matter who they are or where they live.

Product: Clinically Validated AI-enabled
Global Mental Healthcare Platform

Company: Intellect

About the Product:

Intellect is a clinically validated, AI-enabled global mental healthcare platform transforming how people access and receive mental health support. Its integrated continuum of care spans prevention, self-guided therapeutic programmes, AI-enabled support, behavioural health coaching, therapy, and clinical care, guiding individuals to the right level of support for their needs. Backed by peer-reviewed research, including randomised controlled trials, Intellect combines clinical science, technology, and human care to deliver measurable mental health outcomes at scale. Today, Intellect supports more than 4 million lives across 100+ countries and 40+ languages, making high-quality, personalised mental healthcare more accessible across diverse populations worldwide.

Product: CloudCare

Company: Life365

About the Product:

The most expensive moments in healthcare rarely arrive without warning, yet reactive care cannot watch patients between visits. CloudCare, forged over five years with the Department of Veterans Affairs, closes that gap by turning continuous patient-generated data into real-time early warnings, so care teams intervene days before a crisis. The results are striking: a 2.6% heart failure readmission rate versus 20% nationally, and a 60% reduction in ER utilization. Protected by 12 U.S. patents, and reaching patients without smartphones or broadband, CloudCare extends proactive, AI-driven care to the veterans, seniors, and rural patients healthcare leaves behind.

Product: Medable Agentic Clinical Development Platform

Company: Medable

About the Product:

Product: PHIL Digital Hub & PHIL Direct

Company: PHIL Inc.

About the Product:

PHIL helps pharma brands maximize access, affordability, and adherence. We combine a technology-driven hub, direct-to-patient services, integrated dispense network, and end-to-end data capabilities into one powerful platform built to improve outcomes and brand performance. Through human-first support and AI-powered technology, we design custom access programs tailored to fit each brand’s unique goals and patients. We dynamically route patients to the most efficient and affordable access pathways, ensuring they can start and stay on therapy. Brands using PHIL achieve 2x+ patient starts, 2x+ covered dispenses, 3x+ refill adherence, and 3x+ gross-to-net performance compared to traditional access channels.

Product: Rapid Navigator Pro™

Company: RapidAI

About the Product:

Rapid Navigator Pro is an innovative digital health solution transforming radiology workflows through deep clinical AI integration. Built to reduce cognitive burden amidst rising case volumes, it serves as a unified workspace embedded directly within existing PACS infrastructure. The platform features AI-driven worklist prioritization to triage critical cases instantly, an advanced visualization assistant for localized disease metrics, and automated report generation to eliminate manual entry errors. By bridging the gap between automated image interpretation and cross-disciplinary clinical action, Navigator Pro accelerates diagnostic decision-making, mitigates radiologist burnout, and elevates the standard of acute patient care.

Product: AI-powered Medical Benefit Prior Authorization Intelligence Platform

Company: SamaCare

About the Product:

SamaCare is an AI-powered medical benefit prior authorization platform that helps patients access provider-administered specialty therapies faster. The platform unifies prior authorization creation, submission, tracking, and management across payers, plans, therapies, and sites of care, reducing administrative burden for specialty practices while improving visibility into patient access barriers. By transforming real-world prior authorization submissions, payer policies, provider workflows, and payer responses into actionable intelligence, SamaCare helps providers avoid preventable delays and denials. The company also equips life sciences teams with insights to identify access friction, support providers, and improve the script-to-therapy journey for patients.

Product: The TeleDentists® Virtual Dental Care Platform

Company: The TeleDentists

About the Product:

The TeleDentists® Virtual Dental Care Platform is a 24/7 virtual dental care solution that connects patients with licensed dentists through video, mobile, phone, and web consultations. It provides rapid support for dental emergencies, pain, infections, pediatric concerns, oral-health questions, and treatment navigation—often within minutes, from home. The platform expands access for rural, underserved, uninsured, and after-hours patients and families while helping healthcare organizations, emergency departments, senior care facilities, insurers, and employers integrate oral health into broader care pathways. Dentists provide guidance, prescribe when appropriate, and refer patients for in-person treatment, creating a virtual front door for timely, affordable oral healthcare.

Product: The Welldoc Platform

Company: Welldoc

About the Product:

Welldoc® is an AI-powered health technology leader connecting people to more personalized care. The Welldoc platform proactively delivers clinically validated personalized guidance to help individuals navigate complex conditions, from diabetes and obesity to oncology and brain health. 
 
The foundation of Welldoc's solution is Healthcare-Ready AI, a purpose-built engine grounded in unmatched clinical rigor and FDA Class II capabilities. It allows individuals to connect 400+ devices and data sources, while integrating seamlessly with EHR systems, enabling comprehensive interoperability. 

Welldoc partners across multiple healthcare sectors, including life sciences, pharma and health tech, enabling sophisticated health programs driving better engagement, outcomes and savings.